CLINICAL_TRIALS
trial_result
· 2016-02-03
Clinical Trial Update: NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Summary
Phase 3 trial of NWP09 in children with ADHD has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2016-02-03